FDA Proved Lansoprazole for Injection of Inhibiting Gastric Acid
Basic Info
Model No.: DAWALFI0001
Product Description
Model NO.: DAWALFI0001 Usage Mode: For external use State: Solid Type: Biological Products Name: Lansoprazole for Injection MOQ: 1 Box Trademark: GUYENNE Origin: France Application: Internal Medicine Suitable for: Elderly, Children, Adult Shape: Powder Pharmaceutical Technology: Chemical Synthesis Administration Route: I.V OEM: Acceptable Specification: 30mg FDA Proved Lansoprazole For Injection Of Inhibiting Gastric Acid
Lansoprazole is a proton-pump inhibitor (PPI) which inhibits the stomach's production of gastric acids.
It is a proton-pump inhibitor (PPI) in the same pharmacologic class as omeprazole. Lansoprazole has been marketed for many years and is one of several PPIs available. It is a racemic 1:1 mixture of the enantiomers dexlansoprazole (Dexilant, formerly named Kapidex) and levolansoprazole. Dexlansoprazole is an enantiomerically pure active ingredient of a commercial drug as a result of the enantiomeric shift.
Lansoprazole's plasma elimination half-life (1.5 h) is not proportional to the duration of the drug's effects to the person (i.e. gastric acid suppression). and the effects of the drug last for over 24 hours after it has been used for a day or more. Lansoprazole, 30-mg administered nasogastrically, effectively controls intragastric pH and is an alternative to intravenous pantoprazole in patients who are unable to swallow solid-dose formulations.
Indications
Lansoprazole is indicated for treatment of:
Ulcers of the stomach and duodenum, and NSAID-induced ulcers
Gastroesophageal reflux disease
Zollinger-Ellison syndrome
Side effects
Common: diarrhea, abdominal pain
Infrequent: dry mouth, insomnia, drowsiness, blurred vision, rash, pruritus
Rarely and very rarely: taste disturbance, liver dysfunction, peripheral oedema, hypersensitivity reactions (including bronchospasm, urinary, angioedema, anaphylaxis), photosensitivity, fever, sweating, depression, interstitial nephritis, blood disorders (including leukopenia, leukocytosis, pancytopenia, thrombocytopenia), arthralgia, myalgia, skin reactions including (erythroderma Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous eruption)
PPIs may be associated with a greater risk of hip fractures and Clostridium difficile-associated diarrhea. Contact us if you need more details on Gastric Ulcer. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Prevacid、Reflux Esophagitis. If these products fail to match your need, please contact us and we would like to provide relevant information.
| Specification | 30mg |
| Package | 10vials/tray/box |
Lansoprazole is a proton-pump inhibitor (PPI) which inhibits the stomach's production of gastric acids.
It is a proton-pump inhibitor (PPI) in the same pharmacologic class as omeprazole. Lansoprazole has been marketed for many years and is one of several PPIs available. It is a racemic 1:1 mixture of the enantiomers dexlansoprazole (Dexilant, formerly named Kapidex) and levolansoprazole. Dexlansoprazole is an enantiomerically pure active ingredient of a commercial drug as a result of the enantiomeric shift.
Lansoprazole's plasma elimination half-life (1.5 h) is not proportional to the duration of the drug's effects to the person (i.e. gastric acid suppression). and the effects of the drug last for over 24 hours after it has been used for a day or more. Lansoprazole, 30-mg administered nasogastrically, effectively controls intragastric pH and is an alternative to intravenous pantoprazole in patients who are unable to swallow solid-dose formulations.
Indications
Lansoprazole is indicated for treatment of:
Ulcers of the stomach and duodenum, and NSAID-induced ulcers
Gastroesophageal reflux disease
Zollinger-Ellison syndrome
Side effects
Common: diarrhea, abdominal pain
Infrequent: dry mouth, insomnia, drowsiness, blurred vision, rash, pruritus
Rarely and very rarely: taste disturbance, liver dysfunction, peripheral oedema, hypersensitivity reactions (including bronchospasm, urinary, angioedema, anaphylaxis), photosensitivity, fever, sweating, depression, interstitial nephritis, blood disorders (including leukopenia, leukocytosis, pancytopenia, thrombocytopenia), arthralgia, myalgia, skin reactions including (erythroderma Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous eruption)
PPIs may be associated with a greater risk of hip fractures and Clostridium difficile-associated diarrhea. Contact us if you need more details on Gastric Ulcer. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Prevacid、Reflux Esophagitis. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Gastro-Intestinals Drug
Email to this supplier
Other Products
Hot Products
High Quality 200mg Amiodarone Hydrochloride TabletsLarge Stock Whiten Skin Monobenzone CreamGeneral Medicine Omeprazole 20mg Injection for Gastrohelcosis and Stomach AcidGeneral Medicine Ceftriaxone Sodium InjectionPharmaceutical Chlornitromycin CAS 56-75-7 Chloroamphenicol for Veterinary Use (Oap-014)Ready Stock Skin Whitening Anti-Aging Vitamin C InjectionCAS 57-85-2 Injectable Steroid Compound Testosterone PropionateHigh Quality Usnic Acid with High PurityMuscle Builder Weight Loss Homebrew Steroids Testosterone SustanonFDA Approved Curative Antimalarial ArtemisininMedicine Treating Brain Injury Citicoline Sodium InjectionProtease Alpha Chymolase for Inflammatory EdemaGeneral Medicine Medroxyprogesterone Acetate InjectionAmikacin Injection General Medicine DrugsSkin Whitening Gsh Personal Care Glutathione InjectionBody Slimming Fitness Lose Weight Weight Loss L-Carnitine Injection2.0g/5ml